SurModics Inc (NASDAQ:SRDX)

22.80
Data as of Apr 17
 +0.32 / +1.42%
Today’s Change
19.24
Today|||52-Week Range
27.41
-6.52%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$305.0M

Company Description

SurModics, Inc. is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company offers surface modification coating technologies and components for in vitro diagnostic test kits and microarrays. It operates through two segments: Medical Device and In Vitro Diagnostics. The Medical Device segment engages in offering surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device to coronary, peripheral, and neuro-vascular, and urology markets. The In Vitro Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications. Its products include protein stabilization reagents, substrates, antigens and surface coatings for molecular diagnostic applications. SurModics was founded in June 1979 and is headquartered in Eden Prairie, MN.

Contact Information

SurModics, Inc.
9924 West 74th Street
Eden Prairie Minnesota 55344-3523
P:(952) 500-7000
Investor Relations:

Employees

Shareholders

Mutual fund holders45.20%
Individual stakeholders40.21%
Other institutional37.72%

Top Executives

Gary R. MaharajPresident, Chief Executive Officer & Director
Andrew D. C. LaFrenceChief Financial Officer & Vice President
Charles W. OlsonSenior Vice President & GM-Medical Device
Timothy J. ArensVice President-Corporate Development & Strategy
Joseph J. StichVP-Business Operations & GM-In Vitro Diagnostics

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.